Log in using OpenID

Lung Cancer Therapeutics Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025 by Future Market Insights

Lung cancer is a malignant tumor characterized by uncontrolled growth of cell tissues in the lung. Itis the second most commonly diagnosed and has the highest mortality rate of all cancers in both men and women. American Lung Association has estimat
Global Lung Cancer
Therapeutics Market
Share, Global Trends,
Analysis, Research, Report,
Segmentation and Forecast,
Future Market Insights
[email protected]
Report Description
Lung cancer is a malignant tumor characterized by uncontrolled growth of cell tissues in
the lung. Itis the second most commonly diagnosed and has the highest mortality rate of
all cancers in both men and women. American Lung Association has estimated that
around 224,210new cases were diagnosed with lung cancer in the American region that
accounts for approximately 13% of all the cancer cases diagnosed. Thus, with the rise in
incidence rate of lung cancer, the demand for therapeutics is also expected to grow
during the study period.
Based on the cancer cell types, lung cancer is broadly segmented as small cell lung cancer
and non-small cell lung cancer (NSCLC). NSCLC segment accounts for approximately 80 to
90% of all lung cancers. Based on the cell shape and size, NSCLC is further divided to
three subtypes, they are adenocarcinoma, large-cell carcinoma and squamous cell
carcinoma. These NSCLC’s are primarily treated with the surgeries, at the same time
chemotherapy is increasingly used for both pre-operative and post-operative treatment
of the patients. The treatment options available for the NSCLC include surgery, radiation
therapy and chemotherapy. As per the American Cancer Society, it was estimated that in
the United States approximately 195,000 peopleare suffering from NSCLC every year and
the number of deaths from NSCLC are approximately 135,000. The top five global brands
that are commercially available in the market are Avastin, Tarceva, Alimta, Gemzar and
Taxotere. Thus, all the above mentioned factors collectively drive the growth of the global
lung cancer therapeutics market.
Browse Full [email protected]
Report Description
The global lung cancer therapeutics market can be segmented as follows:
By Drugs
• Hycamtin
• Taxotere
• Gemzar
• Alimta
• Iressa
• Avastin
• Tarceva
Pipeline Drugs
• Xalkori
• Afatinib
• Dacomitinib
• ARQ 197
• Talactoferrin
Report Description
Increasing incidences of lung cancer due to rising smoking population is one of the major
factors driving the growth of lung cancer therapeutics market. The risk of lung cancer is
tenfold higher in smokers as compared to non-smokers. In addition, launch of premium
priced drugs, new innovative radiation therapies coupled with rising incidences of NSCLC
are the major driving factors for the growth of lung cancer therapeutics market. However,
genericization of the major drugs might restrict the growth of this market.
Request Report [email protected]
Geographically, North America and Europe dominates the global lung cancer therapeutics
market. According to Lung Disease Research Funding, approximately 75,000 people in the
U.S. die because of lung injury every year. The United States is the largest market for
NSCLC owing to the high incidence rate, rise in aging population. In addition, with advent
of new treatment therapies such as targeted drug therapy, stereotacticsare aiding patient
population. Europe accounts to be the largest market after North America.While, AsiaPacific countries such as India and China, South East Asia are the emerging regions for the
global lung cancer therapeutics market due to high prevalence of this diseasecoupled
with increasing healthcare awareness.
Players are adopting various strategies to expand their product portfolio and increase its
geographical presence. New product development, agreements and collaborations and
acquisitions are some of the important strategies adopted by the players in the global
lung cancer therapeutics market. The prominent leading players of this market include
AstrazenecaPlc, Eli Lilly and Company, GlaxoSmitKline, Hoffman-La Roche,
About Us
Future Market Insights (FMI) is a premier provider of syndicated
research reports, custom research reports, and consulting services.
We deliver a complete packaged solution, which combines current
market intelligence, statistical anecdotes, technology inputs,
valuable growth insights, aerial view of the competitive
framework, and future market trends.
We provide research services at a global as well as regional level;
key regions include GCC, ASEAN, and BRIC.
Research Capabilities
Customized Research
Syndicated Research
Investment Research
Social Media Research
Sector Coverage
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Thank You!
To know more about us, please visit our website:
For sales queries or new topics email us on:
[email protected]
For other queries contact: Mr. Sudip Saha
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705
Ethansmith84   documents Email
Health and Medicine
File Size
454 KB
Report inappropriate content